Sunshine Biopharma (SBFMW) Treasury Shares (2022 - 2023)

Sunshine Biopharma (SBFMW) reported Treasury Shares of $257.0 for Q4 2023, little changed quarter-over-quarter from $257.0 in Q3 2023.

Sunshine Biopharma (SBFMW) Treasury Shares (2022 - 2023) Analysis & Trends

Sunshine Biopharma has reported Treasury Shares for 2 years, with the latest figure at $257.0 in Q4 2023.

For the quarter ending Q4 2023, Treasury Shares changed N/A year-over-year to $257.0; the trailing twelve-month figure through Dec 2023 stood at $257.0 (changed N/A YoY), and the FY2023 full-year result was $257.0, changed N/A from the prior year.
Treasury Shares for Q4 2023 stood at $257.0, roughly flat from $257.0 in the prior quarter.
The five-year high for Treasury Shares was $990000.0 in Q2 2022, with the low at -$990000.0 in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Teva Pharmaceutical Industries	39.97 Bn	36.23 Bn	1.97 Bn	107.00 Mn
2	Zoetis	33.59 Bn	31.65 Bn	1.62 Bn	11.29 Bn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	1.42 Mn
4	Neurocrine Biosciences	16.10 Bn	14.78 Bn	800.70 Mn	-
5	Aurora Cannabis	15.56 Bn	15.47 Bn	21.72 Mn	-
6	Elanco Animal Health	12.04 Bn	11.61 Bn	785.00 Mn	-
7	Alkermes	7.36 Bn	6.84 Bn	-116.06 Mn	501.43 Mn
8	Lantheus Holdings	6.74 Bn	6.24 Bn	230.92 Mn	477.44 Mn
9	Liquidia	6.27 Bn	6.04 Bn	121.79 Mn	5.08 Mn
10	Sunshine Biopharma	-	-	2.18 Mn	-

Download Data